Recently, Shanghai Boku Biotechnology Co., Ltd. (referred to as “Boku Biotech”) completed a tens of millions of RMB Series A financing round, which was exclusively invested by Yizhan Capital.
Public information shows that Boku Biotech, established in 2022, is a diversified biotechnology company focused on the industrial microbiology field. Its key research and industrialization areas are bio-based surfactants. The company has successfully developed seven products, including lactone-type sophorolipids, acid-type sophorolipids, rhamnolipids, fermented rapeseed oil, fermented shea butter oil, fermented camellia seed oil, and fermented seabuckthorn oil. These samples have been successfully applied in personal care and household cleaning products as alternatives to traditional surfactants.
It is worth noting that Unilever has announced its goal to replace all chemical surfactants in its end products with bio-based surfactants by 2030. Dow has announced a partnership with Locus PI to add 100% bio-based surfactants to its products. L’Oréal has also announced that their 2030 green and sustainable development goal is to incorporate 95% bio-based surfactants into their product formulations.
Yizhan Capital stated, “Currently, it is a shared goal among governments, manufacturers, brands, and customers to replace petroleum-based ingredients with renewable bio-based ingredients. Bio-based surfactants have a broad application prospect in the future.”
